Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04109053

Ultrasensitive Electroanatomic Mapping to Adjudicate Endpoints for Ablation In Paroxysmal AF Patients Using Cryoballoon

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
BayCare Health System · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Ultrasensitive Electroanatomic Mapping to Adjudicate Endpoints for Ablation In Paroxysmal AF Patients Using Cryoballoon

Detailed description

Collected data include procedural parameters relevant to pulmonary vein isolation as outlined in the protocol section, DE identified patient demographics, follow up information including rhythm status, antiarrhythmic medication usage, and symptoms or signs to suggest procedural complications relevant to the pulmonary vein isolation procedure.

Conditions

Timeline

Start date
2020-03-02
Primary completion
2021-03-31
Completion
2021-04-30
First posted
2019-09-30
Last updated
2025-10-01

Source: ClinicalTrials.gov record NCT04109053. Inclusion in this directory is not an endorsement.

Ultrasensitive Electroanatomic Mapping to Adjudicate Endpoints for Ablation In Paroxysmal AF Patients Using Cryoballoon (NCT04109053) · Clinical Trials Directory